Metabolic syndrome prevalence in different affective temperament profiles in bipolar-I disorder

Basit Öğe Kaydı
dc.authoridGuloksuz, Sinan/0000-0002-6626-1874
dc.contributor.authorAltinbas, Kursat
dc.contributor.authorGuloksuz, Sinan
dc.contributor.authorOral, E. Timucin
dc.date.accessioned2025-01-27T21:05:36Z
dc.date.available2025-01-27T21:05:36Z
dc.date.issued2013
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstractObjective: Temperament originates in the brain structure, and individual differences are attributable to neural and physiological function differences. It has been suggested that temperament is associated with metabolic syndrome (MetS) markers, which may be partly mediated by lifestyle and socioeconomic status. Therefore, we aim to compare MetS prevalence between different affective temperamental profiles for each season in bipolar patients. Methods: Twenty-six bipolar type-I patients of a specialized outpatient mood disorder unit were evaluated for MetS according to new definition proposed by the International Diabetes Federation in the four seasons of a year. Temperament was assessed using the Temperament Evaluation of Memphis, Pisa, Paris and San Diego - autoquestionnaire version (TEMPS-A). Results: The proportions of MetS were 19.2, 23.1, 34.6, and 38.5% in the summer, fall, spring, and winter, respectively. Only depressive temperament scores were higher (p = 0.002) during the winter in patients with MetS. Conclusion: These data suggest that depressive temperament profiles may predispose an individual to the development of MetS in the winter.
dc.description.sponsorshipEuropean Community; European Accreditation Committee in CNS (Spinoza Grant); Psychiatric Association of Turkey
dc.description.sponsorshipKursat Altinbas reports no potential conflicts of interest. Sinan Guloksuz has received grants from the European Community's Seventh Framework Program (EU-FP7), from the European Accreditation Committee in CNS (Spinoza Grant), and from the Psychiatric Association of Turkey (visiting scholar). E. Timucin Oral has received speaker's honoraria from Lundbeck, Pfizer, Sanofi, AstraZeneca, and GlaxoSmithKline, and has worked as ?a consultant/advisor for Bristol-Myers Squib, AstraZeneca, Lundbeck, and Jansen.
dc.identifier.doi10.1590/1516-4446-2011-0746
dc.identifier.endpage135
dc.identifier.issn1809-452X
dc.identifier.issue2
dc.identifier.pmid23904017
dc.identifier.scopus2-s2.0-84881004347
dc.identifier.scopusqualityQ1
dc.identifier.startpage131
dc.identifier.urihttps://doi.org/10.1590/1516-4446-2011-0746
dc.identifier.urihttps://hdl.handle.net/20.500.12428/27726
dc.identifier.volume35
dc.identifier.wosWOS:000322543200006
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherAssoc Brasileira Psiquiatria
dc.relation.ispartofRevista Brasileira De Psiquiatria
dc.relation.publicationcategoryinfo:eu-repo/semantics/openAccess
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20250125
dc.subjectBipolar disorder
dc.subjecttemperament
dc.subjectmetabolic syndrome
dc.titleMetabolic syndrome prevalence in different affective temperament profiles in bipolar-I disorder
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu